Sectoral Asset Management Inc. lessened its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) by 3.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 95,400 shares of the biotechnology company’s stock after selling 3,400 shares during the period. […]
Retirement Systems of Alabama grew its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) by 0.3% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 332,712 shares of the biotechnology company’s stock after acquiring an additional 936 shares during the period. Retirement Systems of […]
Vanguard Capital Wealth Advisors cut its holdings in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) by 15.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,435 shares of the biotechnology company’s stock after selling 1,400 shares during the […]